Positive results for the use of neoadjuvant cemiplimab in people with cutaneous squamous cell carcinoma (CSCC) were published in New England Journal of Medicine (NEJM) and presented at the European Society of Medical Oncology held in Paris this week.
New research published in Science Advances today conducted by researchers at Peter MacCallum Cancer Centre show a new treatment for two challenging blood cancers could potentially help more patients than originally thought.
Experts from Peter Mac stepped into the international spotlight over the weekend, giving lectures and presenting their research findings at the 2022 European Society of Medical Oncology congress in Paris.
The Peter MacCallum Cancer Centre acknowledges the traditional
owners of the land on which our five sites are located throughout Victoria.
We recognise their strength and resilience and pay our respects
to their Elders past and present.